Every weekday, the CNBC Investing Club with Jim Cramer shares a timely update for stock traders. This week, stocks are on the rise for the second consecutive day. Energy companies, particularly Exxon Mobil and Chevron, are seeing gains. There’s optimism surrounding their potential role in restoring Venezuela’s oil sector after recent events. Meanwhile, major financial firms like Goldman Sachs and Wells Fargo are hitting new impressive heights.
However, not all sectors are thriving. The health care industry is facing challenges. Key players like Eli Lilly, Bristol Myers, and Johnson & Johnson are seeing losses between 1% and 4%. Eli Lilly’s decline could be linked to news from rival Novo Nordisk, which has launched a new oral medication for weight loss in the U.S. This market shift is significant, as Eli Lilly is preparing to introduce its own similar treatment soon.
Experts believe that these oral medications could become more popular than injections. They are generally more convenient to use and store, appealing to patients’ preferences. A report from Wolfe Research anticipates that Eli Lilly’s new medication could bring in around $3.3 billion in sales in its first year after launch.
Next week brings the annual JPMorgan Healthcare Conference, where many health companies will discuss potential partnerships and upcoming earnings. This event often sheds light on key industry trends.
In summary, while the energy and financial sectors show strong performance, health care faces a tough challenge right now. For traders, it’s crucial to stay informed about these shifts.
Source link
Homestretch,Breaking News: Markets,Markets,Investment strategy,Jim Cramer,Exxon Mobil Corp,Chevron Corp,Goldman Sachs Group Inc,Wells Fargo & Co,Capital One Financial Corp,BlackRock Inc,Danaher Corp,Eli Lilly and Co,Bristol-Myers Squibb Co,AbbVie Inc,Johnson & Johnson,Amgen Inc,Novo Nordisk A/S,Novo Nordisk A/S,business news
